# Lyell Immunopharma, Inc.: Form 8-K, filed Sep 10, 2026

- Company: [Lyell Immunopharma, Inc.](/companies/lyel.md) (CIK 1806952)
- Form: 8-K
- Filed: 2026-09-10
- Accepted by EDGAR: Sep 10, 2026, 20:13 ET
- Period: 2026-09-10
- Accession: 0001193125-26-387890
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1806952/000119312526387890/d278670d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1806952/000119312526387890/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1806952/000119312526387890/d278670d8k.htm

Filed Sep 10, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-387890. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.